Apatinib: all 412 studies that test it
Page 3 of 5. Open to participants first (94), then studies with results posted, then the rest; newest registration first within each.
- Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG RegimenStatus unknownNCT04101929Phase 2
- Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy RegimensStatus unknownNCT04089657Phase 2
- A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)TerminatedNCT04073615Phase 1
- Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian CancerStatus unknownNCT04068974Phase 2
- Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal CancerStatus unknownNCT04067986Phase 1/2
- Camrelizumab Combined With Apatinib for Recurrent Resistant GTNCompletedNCT04047017Phase 2
- Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver TransplantStatus unknownNCT04035876Phase 1/2
- SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular CarcinomaStatus unknownNCT04014101Phase 2
- Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue SarcomaStatus unknownNCT04012827Phase 2
- PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric AdenocarcinomaStatus unknownNCT04006821Phase 2
- Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian CancerStatus unknownNCT04000295Phase 3
- Apatinib Plus SHR1210 in Advanced Mucosal MelanomaStatus unknownNCT03986515Phase 2
- Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast CancerActive, not recruitingNCT03982485Phase 2
- PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral MelanomaStatus unknownNCT03955354Phase 2
- Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric CancerStatus unknownNCT03954756Phase 2
- Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric CancerStatus unknownNCT03950141Phase 2
- A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBCCompletedNCT03945604Phase 1
- Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian CancerStatus unknownNCT03942068Phase 2
- Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast CancerStatus unknownNCT03932526Phase 2
- The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCCStatus unknownNCT03917966Phase 2
- Apatinib in the Treatment of Recurrence or Metastasis of Esophageal CancerStatus unknownNCT03913182Phase 2
- The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric CancerStatus unknownNCT03889626Phase 3
- Neoadjuvant Immunotherapy for Resectable Gastric CancerCompletedNCT03878472Phase 2
- Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in ChildrenStatus unknownNCT03868852Phase 1/2
- Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical ResectionStatus unknownNCT03839550Phase 2
- SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical CancerCompletedNCT03816553Phase 2
- A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic TherapyCompletedNCT03813784Phase 3
- FUSCC Refractory TNBC Umbrella (FUTURE)Status unknownNCT03805399Phase 1/2
- Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLCStatus unknownNCT03801200Phase 2
- A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCCStatus unknownNCT03793725Phase 2
- Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based RegimenWithdrawnNCT03792503Phase 4
- Apatinib Combined With POF for Second-line Treatment of Gastric AdenocarcinomaStatus unknownNCT03788174Phase 2
- A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With ApatinibWithdrawnNCT03787251Phase 2
- Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in Subjects With KRAS Mutant Stage IV Non-squamous Non-small Cell Lung CancerTerminatedNCT03777124Phase 2
- Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast CancerStatus unknownNCT03775928Phase 2
- Apatinib Combined With Chemotherapy for NSCLC Patients Without T790M MutationStatus unknownNCT03758677Phase 2
- Biomarkers for Apatinib and Bevacizumab in Second-line Therapy for Colorectal Cancer(BABST-C)SuspendedNCT03743428Not applicable
- TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCTStatus unknownNCT03741244Phase 2
- Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast CancerStatus unknownNCT03735082Phase 2
- Apatinib for Advanced Lung Squmamous CarcinomaStatus unknownNCT03725423Phase 4
- SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After SurgeryStatus unknownNCT03722875Not applicable
- A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer CellsStatus unknownNCT03718624Phase 2
- Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid CarcinomaStatus unknownNCT03709953Phase 2
- Study of the Combination of Apatinib and POFStatus unknownNCT03707639Phase 2
- A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction CancerTerminatedNCT03707028Phase 1/2
- Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder CarcinomaStatus unknownNCT03702491Phase 2
- Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic CancerStatus unknownNCT03662035Phase 2
- Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant TumorsCompletedNCT03660761Phase 2
- Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck MalignanciesStatus unknownNCT03654612Phase 1/2
- Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung CancerStatus unknownNCT03651219Phase 3
- This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant Therapy of Triple-negative Breast Cancer, as Well as the Safety of TreatmentStatus unknownNCT03650738Phase 2
- Treatment of Carrying TP53 Harmful MutationsStatus unknownNCT03645200Phase 1
- A Study of Apatinib Plus EGFR-TKI as First Line Treatment in Patients With Non-squamous NSCLC Harboring EGFR MutationsStatus unknownNCT03634059Not applicable
- Treatment of Newly Diagnosed Peripheral T-cell LymphomaStatus unknownNCT03631862Phase 4
- Adjuvant Treatment of Apatinib in Nasopharyngeal CarcinomaStatus unknownNCT03612219Phase 2
- A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary CarcinomaStatus unknownNCT03609489Phase 2
- XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric AdenocarcinomaStatus unknownNCT03599778Phase 1/2
- Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric CancerStatus unknownNCT03598348Phase 3
- Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian CancerTerminatedNCT03587129Phase 2
- Apatinib in Neoadjuvant Therapy for Patients With Breast CancerStatus unknownNCT03580395Phase 2/3
- A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung CancerCompletedNCT03547804Phase 2
- Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard ChemotherapyStatus unknownNCT03547375Phase 2
- Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.Status unknownNCT03546855Phase 2
- Apatinib as First -Line Treatment for Advanced Esophagus CancerStatus unknownNCT03542422Phase 2
- Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS StudyStatus unknownNCT03539172Phase 2
- Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast CancerCompletedNCT03535961Phase 2
- A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic CholangiocarcinomaStatus unknownNCT03521219Phase 2
- The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma PatientsStatus unknownNCT03511703Phase 2
- Efficacy and Safety of Apatinib Combined With TACE in Patients With Hepatocellular CarcinomaStatus unknownNCT03510416Phase 2
- Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid TumorsStatus unknownNCT03491631Phase 1
- Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker CorrelationsStatus unknownNCT03475589Phase 4
- Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast CancerStatus unknownNCT03457467Phase 2
- Apatinib for Advanced Biliary CarcinomaStatus unknownNCT03427242Phase 2
- A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT03424291Phase 2
- A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced MelanomaStatus unknownNCT03422445Phase 2
- Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)Status unknownNCT03416231Phase 2
- Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal CancerStatus unknownNCT03412994Phase 2
- Apatinib in Combination With Docetaxel for Patients With Advanced NSCLCStatus unknownNCT03411967Phase 2
- Apatinib With Pembrolizumab in Previously Treated Advanced MalignanciesTerminatedNCT03407976Phase 1
- Apatinib in the Treatment of Metastatic Colorectal CancerStatus unknownNCT03403452Phase 2
- Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal CancerStatus unknownNCT03397199Phase 2
- A Study to Evaluate Apatinib (Also Known as Rivoceranib) Plus Nivolumab in Participants With Unresectable or Metastatic CancerCompletedNCT03396211Phase 1
- A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBCCompletedNCT03394287Phase 2
- A Study of Apatinib Treatment in for Advanced Ovarian CancerStatus unknownNCT03393507Phase 2
- A Study of Apatinib in Recurrent or Recurrent High-grade GliomaStatus unknownNCT03390062Phase 2
- Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLCStatus unknownNCT03389256Phase 2
- Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung CancerStatus unknownNCT03389087Phase 2
- The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.CompletedNCT03384511Phase 4
- Clinical Study of Apatinib as the Second-line Therapy in Malignant MelanomaStatus unknownNCT03383237Phase 2
- Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal CancerStatus unknownNCT03377842Phase 2
- Apatinib for Relapsed and Refractory Diffuse Large B Cell LymphomaCompletedNCT03376958Phase 4
- Study of Apatinib as the Maintenance Therapy in Advanced Lung AdenocarcinomaStatus unknownNCT03376737Phase 2
- mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal CancerCompletedNCT03365765Phase 3
- Apatinib Plus Anti-PD1 Therapy for Advanced OsteosarcomaCompletedNCT03359018Phase 2
- Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung CancerStatus unknownNCT03356600Phase 2
- A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Siewert II ，III of Locally Advanced HER-2 Negative Adenocarcinoma at Gastroesophageal JunctionStatus unknownNCT03349866Phase 2
- HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric CancerTerminatedNCT03349827Not applicable
- Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast CancerStatus unknownNCT03348098Phase 2
- Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric CancerStatus unknownNCT03334591Phase 2
- Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid CancerStatus unknownNCT03300765Phase 2